Synovial sarcoma, a rare cancer, thrives on glutamine. Blocking its nutrient supply with the drug V9302 stops tumor growth, offering a new way to treat the disease.
There is strong demand for compassionate use of OST-HER2 from the patient community, underscoring the urgent need for new therapies in Human Metastatic Osteosarcoma.” — Paul Romness, MPH, Chairman & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results